Sage Journals: Discover world-class research

Retricted access

Research article

First published 2016-6

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Richard Macdonell, Guy Nagels, David-Axel Laplaud [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2018

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine

Núria Sola-Valls, Yolanda Blanco, María Sepúlveda [...]

Therapeutic Advances in Neurological Disorders

Open access

Review article

First published 2018

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting

Philipp Albrecht, Ingrid Kristine Bjørnå, David Brassat [...]

Therapeutic Advances in Neurological Disorders

Open access

Research article

First published 2016-2

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Raymond Hupperts, Jan Lycke, Christine Short [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2022

Efficacy of prolonged-release fampridine versus placebo on walking ability,dynamic and static balance,physical impact of multiple sclerosis,and quality of life: an integrated analysis of MOBILE and ENHANCE

Raymond Hupperts, Claudio Gasperini, Jan Lycke [...]

Therapeutic Advances in Neurological Disorders

Retricted access

Research article

First published 2016-10

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Björn Zörner, Linard Filli, Katja Reuter [...]

Multiple Sclerosis Journal

Open access

Case report

First published 2022

Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report

Mona Klara Ros Müller, Monika Christ, Markus Naumann [...]

Therapeutic Advances in Neurological Disorders

Search results

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

Combined walking outcome measures identify clinically meaningful response to prolonged-release fampridine

Prolonged-release fampridine in multiple sclerosis: clinical data and real-world experience. Report of an expert meeting

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial

Efficacy of prolonged-release fampridine versus placebo on walking ability,dynamic and static balance,physical impact of multiple sclerosis,and quality of life: an integrated analysis of MOBILE and ENHANCE

Prolonged-release fampridine in multiple sclerosis: Improved ambulation effected by changes in walking pattern

Prolonged-release fampridine for the treatment of myoclonus after cervical myelitis: a case report